Skip to main content
. 2020 Feb 19;8(2):36. doi: 10.3390/biomedicines8020036

Figure 1.

Figure 1

(A) Scheme of patient inclusion and exclusion criteria in this study; (B) Flow chart of the study. TBLB, transbronchial lung biopsy; EGFR, epidermal growth factor receptor; TKIs, tyrosine kinase inhibitors; PD-L1, programmed death ligand 1; IHC, immunohistochemistry; TPS, tumor proportion scores.